{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"117.800","rs_stock_flag":false,"fiscal_year_end":"","hist_closedate":"","replication_method":null,"amt_os":"78,707,270","primaryexch":"HKEX","ric":"2637.HK","product_subtype":null,"db_updatetime":"20 Oct 2025 09:36","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BVBQP75","am":"204.21","iv":"","ew_strike":"","as":"109.600","geographic_focus":null,"incorpin":"PRC","etp_baseCur":null,"ew_amt_os":"","bd":"109.500","registrar":"Tricor Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"50","update_time":"2025-10-20 01:36:28.0","lo52":"","shares_issued_date":"20 Oct 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Kang Xinshan","underlying_ric":"2637.HK","hi52":"","issuer_name":"Fujian Haixi Pharmaceuticals Co., Ltd. - H Shares","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"20 Oct 2025 10:21","aum_date":"","lo":"100.000","mkt_cap":"8.61","f_aum_hkd":null,"ew_sub_per_to":"","ls":"109.500","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"0","aum":"","issued_shares_class_B":null,"vo":"1.78","secondary_listing_flag":false,"listing_date":"20 Oct 2025","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Fujian Haixi Pharmaceuticals Co., Ltd. - H Shares","nm_s":"HAIXI PHARMA","sym":"2637","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.100","strike_price":"","summary":"Fujian Haixi Pharmaceuticals Co Ltd is a China-based company principally engaged in the research, development, production, and sales of generic drugs and innovative drugs. The Company’s main products include Anbili, Haihuitong, Ruiantuo and Saixifu. The Company’s products are mainly used in digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases, inflammatory diseases, oncology, ophthalmology, respiratory diseases and others. The Company mainly operates its businesses in the domestic market.","op":"102.000","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Pharmaceuticals","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Floor 3 & 4, Block B<br/>No. 177 Jinda Rd, Jianxin Town<br/>Cangshan District, Fuzhou<br/>Fujian Province, PRC","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"","isin":"CNE100007515","moneyness":""}},"qid":"1760927784141"}
